(Q36837149)

English

Smart adjuvants

scientific article published on June 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

Smart adjuvants (English)

1 reference

Europe PubMed Central

16 August 2017

author name string

Clint S Schmidt

1

1 reference

Europe PubMed Central

16 August 2017

W John W Morrow

2

1 reference

Europe PubMed Central

16 August 2017

Nadeem A Sheikh

3

1 reference

Europe PubMed Central

16 August 2017

publication date

1 June 2007

1 reference

Europe PubMed Central

16 August 2017

Expert Review of Vaccines

1 reference

Europe PubMed Central

16 August 2017

6

1 reference

Europe PubMed Central

16 August 2017

3

1 reference

Europe PubMed Central

16 August 2017

391-400

1 reference

Europe PubMed Central

16 August 2017

Aluminium compounds for use in vaccines

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvant

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Differential requirements for CTL generation by novel immunostimulants: APC tropism, use of the TAP-independent processing pathway, and dependency on CD80/CD86 costimulation

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

High titers of circulating maternal antibodies suppress effector and memory B-cell responses induced by an attenuated rotavirus priming and rotavirus-like particle-immunostimulating complex boosting vaccine regimen

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Immunobiology of the Tomatine adjuvant

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Expression of human DEC-205 (CD205) multilectin receptor on leukocytes.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Receptor-mediated gene transfer into macrophages

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Glycosylated cationic liposomes for cell-selective gene delivery

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Liposomal meningococcal B vaccination: role of dendritic cell targeting in the development of a protective immune response.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Selective targeting of liposomes to macrophages using a ligand with high affinity for the macrophage scavenger receptor class A.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Novel bacterial delivery system with attenuated Salmonella typhimurium carrying plasmid encoding Mtb antigen 85A for mucosal immunization: establishment of proof of principle in TB mouse model.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Molecular genetic bases of Salmonella entry into host cells

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Delivery of epitopes by the Salmonella type III secretion system for vaccine development.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Safety and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering an HIV-1 Gag antigen via the Salmonella Type III secretion system.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18)

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Bordetella pertussis adenylate cyclase delivers chemically coupled CD8+ T-cell epitopes to dendritic cells and elicits CTL in vivo.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Delivery of the HIV-1 Tat protein to dendritic cells by the CyaA vector induces specific Th1 responses and high affinity neutralizing antibodies in non human primates.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Listeria monocytogenes: a potent vaccine vector for neoplastic and infectious disease

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Delivery of a viral antigen to the class I processing and presentation pathway by Listeria monocytogenes.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

LAG-3, a novel lymphocyte activation gene closely related to CD4

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Characterization of the major histocompatibility complex class II binding site on LAG-3 protein

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Cellular expression and tissue distribution of the human LAG-3-encoded protein, an MHC class II ligand

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Soluble human LAG-3 molecule amplifies the in vitro generation of type 1 tumor-specific immunity

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

A soluble LAG-3 protein as an immunopotentiator for therapeutic vaccines: Preclinical evaluation of IMP321.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Toll-like receptor control of the adaptive immune responses

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Toll-like receptors

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

The interferon inducer ampligen [poly(I)-poly(C12U)] markedly protects mice against coxsackie B3 virus-induced myocarditis

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Enhancement of antigen-specific immunity via the TLR4 ligands MPL adjuvant and Ribi.529.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

The adjuvant action of cholera toxin is associated with an increased intestinal permeability for luminal antigens

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Immunomodulatory effects of systemic low-dose recombinant interleukin-2 and lymphokine-activated killer cells in humans.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Pilot study of the effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired HIV infection

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Immunotherapy with canarypox vaccine and interleukin-2 for HIV-1 infection: termination of a randomized trial

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Characterization of a novel subset of CD8(+) T cells that expands in patients receiving interleukin-12.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Molecular cloning of cDNA encoding a murine haematopoietic growth regulator, granulocyte-macrophage colony stimulating factor.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Derangement of immune responses by myeloid suppressor cells

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

New hepatitis B vaccine formulated with an improved adjuvant system

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.391

21 January 2018

Identifiers

10.1586/14760584.6.3.391

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36837149&oldid=2127068053"